5 Results for "

lipid self-assembly

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "lipid self-assembly" in MCE Product Catalog:

Cat. No.: HY-154644
CAS No.: 8030-76-0
Soya Lecithin is a phospholipid mixture that can be used as a drug delivery vehicle and is a pharmaceutical excipient. Soya Lecithin can form a lipid bilayer structure through self-assembly, and its binding properties are amphiphilic (hydrophilic head and hydrophobic tail), encapsulating hydrophobic drugs. Soya Lecithin forms stable nanoliposomes or microemulsions, improves the solubility and cellular uptake efficiency of poorly soluble drugs (such as Curcumin (HY-N0005)), and exerts activities such as enhancing drug delivery and regulating cell proliferation .
loading...
    loading...
Cat. No.: HY-121447
CAS No.: 2363-71-5
Purity:  ≥98.0%
Heneicosanoic acid is an odd-chain saturated fatty acid widely present in human milk, fish, seeds, and cerebrosides in the cell membranes of the nervous system. Heneicosanoic acid can form Langmuir monolayers and is often used as a model to study lipid self-assembly and disassembly processes in biological membranes and drug delivery systems. In the low-temperature L'2 and CS crystalline phases, Heneicosanoic acid undergoes local oscillations, which in turn drive the spontaneous formation and expulsion of micelles and vesicles .
loading...
    loading...
Cat. No.: HY-N16152
CAS No.: 106918-69-8
Synonyms: C6-NBD-PE
Target:  

Fluorescent Dye

Research Areas:  

Others

16:0-06:0 NBD PE (C6-NBD-PE) is a commonly used fluorescent phospholipid analog and membrane-disrupting agent for investigating membrane lipid structure and dynamics. In aqueous buffers, the self-assembly of 16:0-06:0 NBD PE can be disrupted via binding to methylated α-, β-, and γ-cyclodextrins. 16:0-06:0 NBD PE can be selectively extracted from lipid vesicles upon the addition of methylated cyclodextrins, with an extraction efficiency lower than that of NBD-PC and NBD-SM analogs .
loading...
    loading...
Cat. No.: HY-184489
CAS No.: 328265-32-3
Research Areas:  

Cancer

PGP/FSP1-IN-1 is a dual PGP and FSP1 inhibitor and ferroptosis inducer that inhibits the oxidoreductase activity of FSP1. PGP/FSP1-IN-1 competes with NAD (P) H for binding to the pocket of FSP1 and induces FSP1 self-assembly, thereby directly blocking the catalytic function of the relevant enzyme. PGP/FSP1-IN-1 promotes lipid peroxidation and significantly enhances cellular sensitivity to ferroptosis when GPX4 activity is impaired or glutathione synthesis is inhibited. PGP/FSP1-IN-1 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-L214
192 compounds

Liposomes are spherical or multilayered spherical vesicles formed by the self-assembly of diacyl chain phospholipids (lipid bilayers) in aqueous solutions, which can be made from natural or synthetic phospholipids and exhibit good biocompatibility and low toxicity. They can serve as delivery carriers for various bioactive substances (such as drugs, proteins, nucleic acids, etc.) and are widely used in biomedical and chemical research. The main advantages of liposomes include 1) Protective effect: Their bilayer structure can protect encapsulated molecules from enzymatic degradation, oxidation, and other influences, extending stability and activity; 2) Active targeting: Surface modifications enable active targeting, enhancing the concentration of drugs or molecules in specific tissues or cells; 3) Customizability: The composition and structure of liposomes can be adjusted according to needs, such as altering phospholipid types or adding targeting ligands. These properties make liposomes highly valuable in developing novel drug delivery systems, serving as nucleic acid carriers for gene transfection, studying cellular uptake mechanisms and drug release kinetics, as well as developing functional food additives to improve the bioavailability of nutritional components.

MCE contains 192 liposome compounds, which is a good tool for drug delivery-related studies.